213 research outputs found
Efficient load balancing and QoS-based location aware service discovery protocol for vehicular ad hoc networks
Active authentication for mobile devices utilising behaviour profiling.
With nearly 6 billion subscribers around the world, mobile devices have become an indispensable component in modern society. The majority of these devices rely upon passwords and personal identification numbers as a form of user authentication, and the weakness of these point-of-entry techniques is widely documented. Active authentication is designed to overcome this problem by utilising biometric techniques to continuously assess user identity. This paper describes a feasibility study into a behaviour profiling technique that utilises historical application usage to verify mobile users in a continuous manner. By utilising a combination of a rule-based classifier, a dynamic profiling technique and a smoothing function, the best experimental result for a users overall application usage was an equal error rate of 9.8 %. Based upon this result, the paper proceeds to propose a novel behaviour profiling framework that enables a user’s identity to be verified through their application usage in a continuous and transparent manner. In order to balance the trade-off between security and usability, the framework is designed in a modular way that will not reject user access based upon a single application activity but a number of consecutive abnormal application usages. The proposed framework is then evaluated through simulation with results of 11.45 and 4.17 % for the false rejection rate and false acceptance rate, respectively. In comparison with point-of-entry-based approaches, behaviour profiling provides a significant improvement in both the security afforded to the device and user convenience
Mda-9/Syntenin Is Expressed in Uveal Melanoma and Correlates with Metastatic Progression
Uveal melanoma is an aggressive cancer that metastasizes to the liver in about half of the patients, with a high lethality rate. Identification of patients at high risk of metastases may provide indication for a frequent follow-up for early detection of metastases and treatment. The analysis of the gene expression profiles of primary human uveal melanomas showed high expression of SDCBP gene (encoding for syndecan-binding protein-1 or mda-9/syntenin), which appeared higher in patients with recurrence, whereas expression of syndecans was lower and unrelated to progression. Moreover, we found that high expression of SDCBP gene was related to metastatic progression in two additional independent datasets of uveal melanoma patients. More importantly, immunohistochemistry showed that high expression of mda-9/syntenin protein in primary tumors was significantly related to metastatic recurrence in our cohort of patients. Mda-9/syntenin expression was confirmed by RT-PCR, immunofluorescence and immunohistochemistry in cultured uveal melanoma cells or primary tumors. Interestingly, mda-9/syntenin showed both cytoplasmic and nuclear localization in cell lines and in a fraction of patients, suggesting its possible involvement in nuclear functions. A pseudo-metastatic model of uveal melanoma to the liver was developed in NOD/SCID/IL2Rγ null mice and the study of mda-9/syntenin expression in primary and metastatic lesions revealed higher mda-9/syntenin in metastases. The inhibition of SDCBP expression by siRNA impaired the ability of uveal melanoma cells to migrate in a wound–healing assay. Moreover, silencing of SDCBP in mda-9/syntenin-high uveal melanoma cells inhibited the hepatocyte growth factor (HGF)-triggered invasion of matrigel membranes and inhibited the activation of FAK, AKT and Src. Conversely syntenin overexpression in mda-9/syntenin-low uveal melanoma cells mediated opposite effects. These results suggest that mda-9/syntenin is involved in uveal melanoma progression and that it warrants further investigation as a candidate molecular marker of metastases and a potential therapeutic target
A Survey of Limitations and Enhancements of the IPv6 Routing Protocol for Low-power and Lossy Networks: A Focus on Core Operations
Driven by the special requirements of the Low-power and Lossy Networks (LLNs), the IPv6 Routing Protocol for LLNs (RPL) was standardized by the IETF some six years ago to tackle the routing issue in such networks. Since its introduction, however, numerous studies have pointed out that, in its current form, RPL suffers from issues that limit its efficiency and domain of applicability. Thus, several solutions have been proposed in the literature in an attempt to overcome these identified limitations. In this survey, we aim mainly to provide a comprehensive review of these research proposals assessing whether such proposals have succeeded in overcoming the standard reported limitations related to its core operations. Although some of RPL’s weaknesses have been addressed successfully, the study found that the proposed solutions remain deficient in overcoming several others. Hence, the study investigates where such proposals still fall short, the challenges and pitfalls to avoid, thus would help researchers formulate a clear foundation for the development of further successful extensions in future allowing the protocol to be applied more widely
ClustalXeed: a GUI-based grid computation version for high performance and terabyte size multiple sequence alignment
Abstract Background There is an increasing demand to assemble and align large-scale biological sequence data sets. The commonly used multiple sequence alignment programs are still limited in their ability to handle very large amounts of sequences because the system lacks a scalable high-performance computing (HPC) environment with a greatly extended data storage capacity. Results We designed ClustalXeed, a software system for multiple sequence alignment with incremental improvements over previous versions of the ClustalX and ClustalW-MPI software. The primary advantage of ClustalXeed over other multiple sequence alignment software is its ability to align a large family of protein or nucleic acid sequences. To solve the conventional memory-dependency problem, ClustalXeed uses both physical random access memory (RAM) and a distributed file-allocation system for distance matrix construction and pair-align computation. The computation efficiency of disk-storage system was markedly improved by implementing an efficient load-balancing algorithm, called "idle node-seeking task algorithm" (INSTA). The new editing option and the graphical user interface (GUI) provide ready access to a parallel-computing environment for users who seek fast and easy alignment of large DNA and protein sequence sets. Conclusions ClustalXeed can now compute a large volume of biological sequence data sets, which were not tractable in any other parallel or single MSA program. The main developments include: 1) the ability to tackle larger sequence alignment problems than possible with previous systems through markedly improved storage-handling capabilities. 2) Implementing an efficient task load-balancing algorithm, INSTA, which improves overall processing times for multiple sequence alignment with input sequences of non-uniform length. 3) Support for both single PC and distributed cluster systems.</p
Elevated expression of syntenin in breast cancer is correlated with lymph node metastasis and poor patient survival
Gene expression profiles of human melanoma cells with different invasive potential reveal TSPAN8 as a novel mediator of invasion
Gene expression analysis after receptor tyrosine kinase activation reveals new potential melanoma proteins
<p>Abstract</p> <p>Background</p> <p>Melanoma is an aggressive tumor with increasing incidence. To develop accurate prognostic markers and targeted therapies, changes leading to malignant transformation of melanocytes need to be understood. In the <it>Xiphophorus </it>melanoma model system, a mutated version of the EGF receptor Xmrk (<it>Xiphophorus </it>melanoma receptor kinase) triggers melanomagenesis. Cellular events downstream of Xmrk, such as the activation of Akt, Ras, B-Raf or Stat5, were also shown to play a role in human melanomagenesis. This makes the elucidation of Xmrk downstream targets a useful method for identifying processes involved in melanoma formation.</p> <p>Methods</p> <p>Here, we analyzed Xmrk-induced gene expression using a microarray approach. Several highly expressed genes were confirmed by realtime PCR, and pathways responsible for their induction were revealed using small molecule inhibitors. The expression of these genes was also monitored in human melanoma cell lines, and the target gene <it>FOSL1 </it>was knocked down by siRNA. Proliferation and migration of siRNA-treated melanoma cell lines were then investigated.</p> <p>Results</p> <p>Genes with the strongest upregulation after receptor activation were FOS-like antigen 1 (<it>Fosl1</it>), early growth response 1 (<it>Egr1</it>), osteopontin (<it>Opn</it>), insulin-like growth factor binding protein 3 (<it>Igfbp3</it>), dual-specificity phosphatase 4 (<it>Dusp4</it>), and tumor-associated antigen L6 (<it>Taal6</it>). Interestingly, most genes were blocked in presence of a SRC kinase inhibitor. Importantly, we found that <it>FOSL1</it>, <it>OPN</it>, <it>IGFBP3</it>, <it>DUSP4</it>, and <it>TAAL6 </it>also exhibited increased expression levels in human melanoma cell lines compared to human melanocytes. Knockdown of <it>FOSL1 </it>in human melanoma cell lines reduced their proliferation and migration.</p> <p>Conclusion</p> <p>Altogether, the data show that the receptor tyrosine kinase Xmrk is a useful tool in the identification of target genes that are commonly expressed in Xmrk-transgenic melanocytes and melanoma cell lines. The identified molecules constitute new possible molecular players in melanoma development. Specifically, a role of FOSL1 in melanomagenic processes is demonstrated. These data are the basis for future detailed analyses of the investigated target genes.</p
- …